retatrutide type 2 diabetes phase 2 results 2024 2025 π may be redefining obesity treatment. New data from TRIUMPH-1 Trial showed: π₯ ~28% average weight loss over 80 weeks π₯ >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Retatrutide (Triple-Action Jab): Phase III
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 12 - Aug 17























